IDEXX Laboratories Inc (IDXX)

NASDAQ · Health Care

566.76
+13.28 (+2.40%)
Updated Oct 22, 10:22 PM ET
AI Rating
Hold
Overall Score
58
Trend
27
Momentum
83
Risk
71

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 7, 2025 260 sessions Oct 19, 2026

AI Analysis

IDEXX Laboratories Inc is trading at $566.76, up 2.40% on the session. The 50 day average sits at $534.63 and the 200 day at $579.07, which puts the stock in a downtrend. RSI is at 63.2, which reads as strong, and MACD is bullish crossover. Volume is average.

The nearest support is around $549.33 with resistance near $561.24, so that band frames the current range. Average daily movement is roughly $13.27, or about 2.3% of the share price, which is what any stop placement has to allow for. The overall health score of 58 out of 100 combines a trend score of 27, momentum of 83 and a risk score of 71.

Technical indicators

RSI (14)
63.2
strong
MACD
4.327
bullish crossover
SMA 20
525.69
SMA 50
534.63
SMA 200
579.07
downtrend
ATR (14)
13.27
avg daily range
Support
549.33
Resistance
561.24
Volume vs 20d
0.97x
average
Volatility
25.1%
annualised
1 month
+8.63%
3 months
+0.61%

About IDEXX Laboratories Inc

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.